Temporal Characterization of Blood–Brain Barrier Disruption with High-Frequency Electroporation

Treatment of intracranial disorders suffers from the inability to accumulate therapeutic drug concentrations due to protection from the blood–brain barrier (BBB). Electroporation-based therapies have demonstrated the capability of permeating the BBB, but knowledge of the longevity of BBB disruption...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzo, Melvin F., Thomas, Sean C., Kani, Yukitaka, Hinckley, Jonathan, Lee, Matthew, Adler, Joy, Verbridge, Scott S., Hsu, Fang-Chi, Robertson, John L., Davalos, Rafael V., Rossmeisl, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966593/
https://www.ncbi.nlm.nih.gov/pubmed/31771214
http://dx.doi.org/10.3390/cancers11121850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966593/
https://www.ncbi.nlm.nih.gov/pubmed/31771214
http://dx.doi.org/10.3390/cancers11121850

Ejemplares similares